Join us on our mission to positively impact the lives of people living with cancer!
Akamis Bio is a clinical-stage oncology company whose mission is to leverage its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to positively impact the lives of people living with cancer. To achieve that mission, Akamis Bio is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics which aim to enable a patient’s own immune system to recognize, attack, and clear their cancer.
If you’d like to join us on our mission, we welcome you to apply to one of our open positions below. We look forward to hearing from you!